Korea Arlico Pharm Co.,Ltd.
Research Korea Arlico Pharm Co.,Ltd. (260660.KQ) on Bullrun: market cap KRW 32.80B, dividend yield 3.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker260660.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 32.80B
- Dividend yield3.4%
- Financial periodQ2 2026
- RevenueKRW 46.85B
- Net income-KRW 693.57M
- Free cash flowKRW 4.24B
- Gross margin47.9%
Valuation Snapshot
latest market cap is KRW 32.80B; dividend yield is 3.4%.
Peer valuation comparison
Latest dividend yield is 3.43% versus a Healthcare sector median of 2.4% (42.9% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 32.80B | n/a | 3.4% | 75 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 75 KRW, yield 3.4%.
About Korea Arlico Pharm Co.,Ltd.
Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. The company provides ETC, OTC, medical device, and other products; and active ingredients. It offers products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Korea Arlico Pharm Co.,Ltd.'s market cap?
Korea Arlico Pharm Co.,Ltd.'s market capitalization is KRW 32.80B.
Does Korea Arlico Pharm Co.,Ltd. pay a dividend?
Korea Arlico Pharm Co.,Ltd. has a dividend yield of 3.4%.
What does Korea Arlico Pharm Co.,Ltd. do?
Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. The company provides ETC, OTC, medical device, and other products; and active ingredients. It offers products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd.